The influence of chemical protection on the content of heavy metals in wheat (Triticum aestivum L.) growing on the soil enriched with granular sludge.

The presence of heavy metals in Triticum aestivum L. growing on the soil enriched with granular sludge after chemical protection was observed. The five variants of treatments using herbicide (Chwastox Turbo 340SL) and four fungicides (Topsin M 500SC, Amistar 250SC, Artea 330EC, and Falcon 460EC) were performed. On control and experimental plots, the concentration of Ni, Pb, Cr, and Cu in wheat leaves were in the range 0.32-0.99, 0.92-1.57, 0.89-6.31, and 7.08-12.59 mg/kg and in grains 0.03 to 0.11, 0.14-0.25, 0.11-0.76, and 1.06-1.46 mg/kg, respectively. The concentration of Pb in grain protected by MCPA and 2,4-D with thiophanate-methyl and azoxystrobin was higher than the maximum levels of 0.20 mg/kg D.M. The bioconcentration factor (BCF) differed and depended on chemical protection. The highest value of BCF was achieved for Cd. The statistical analysis showed a significant correlation between concentration of metals and quality parameters of wheat. One observed significant negative correlations between Ni/Zeleny sedimentation value (r = -0.51) and between Pb/starch content (r = -0.57). Positive correlations were observed between Cd/yield, the number of grains/ergosterol concentration (respectively, r = 0.41, r = 0.55, r = 0.56), and Zn/thousand grain weight (r = 0.50) at a p ≤ 0.05.

[2 cases of Richter's syndrome]. / Dwa przypadki zespolu Richtera.

Two cases of Richter's syndrome are reported (in a 62 and 64 years old man) consistent with the appearance of B cell lymphoma of high malignancy in the course of CLL (low malignancy B cell lymphoma). In one patient, after 8-, and in the other one--after 53 months since the diagnosis of CLL, there was rapid clinical deterioration with lymphadenopathy, hepato- splenomegaly, fever and progressive cachexia, anemia and thrombocytopenia and leukopenia, unrelated to treatment. Both patients died, 4 and 3 months respectively, since the appearance of these symptoms. In the first cases Richter's syndrome was diagnosed histopathologically from the autopsy material. In the liver, spleen, adrenals and bone marrow, in addition to the characteristic infiltrates of CLL (small lymphocytes) there were areas of large cell proliferation consistent with high malignancy lymphoma. In the other case, the infiltrates of large cell lymphoma were found in the gall bladder removed because of acute cholecystitis, and in the lymph node from the hepatic hilar area. Immunocytochemical studies performed on the biopsy material indicated that the neoplastic cells had markers of B lymphocytes and cytoplasmic IgM kappa, as lymphocytes of CLL. In patients with CLL, who display rapid clinical deterioration and general symptoms with cachexia, the possibility of Richter's syndrome should be considered, and appropriate morphological studies performed.

[Preliminary results of the treatment of acute leukemia with mitoxantrone]. / Wstepne wyniki leczenia ostrych bialaczek mitoksantronem.

Mitoxantrone is a new anthracenodione derivative with a high antineoplastic activity in proliferative diseases of the haemopoietic system. In the Institute of Haematology in Warsaw and in the Department of Haematology, Silesian Medical Academy in Katowice this agent was used in combination with cytarabine in 49 cases of acute leukaemia (35 with acute myeloid leukaemia and 14 with acute lymphoblastic leukaemia). The preparations used were Mitoxantrone (POLFA Works in Jelenia Góra) and Novantrone (Lederle). These agents were given intravenously in doses of 10-20 mg/m2 for 3 days in combination with cytarabine in three doses: 100 mg/m2 on days 1 through 7, and 1 g/m2 or 3 g/m2 every 12 hours on days 1 through 4 of the treatment. Complete remission was obtained in 17 cases (35%), including 13 with acute myeloid leukaemia (37%) and 4 with acute lymphoblastic leukaemia (29). The most frequent side effects were: long-lasting pancytopenia (in 100% of cases), hair loss (39%) and gastrointestinal toxicity (33%). No significant differences were noted in the effectiveness and toxicity between these two preparations. In the light of the presented results it may be accepted that the combination of mitoxantrone with cytarabine is an important advance in the treatment of acute leukaemias.